Dan Jacob Gelvan
Directeur Général chez T-Syte Ltd.
Profil
Dan Jacob Gelvan is the founder of Zetiq Technologies Ltd.
and Vecta Ltd.
He currently holds the position of Chief Executive Officer at T-Syte Ltd.
and Chief Executive Officer at Agplenus.
In the past, he has worked as the Chief Executive Officer of Gammacan International, Inc., Chairman & Chief Executive Officer of I2O Pharma Ltd., Chairman of Beta-O2 Technologies Ltd., Director of IntelliDx, Inc., Managing Director of Aurum Ventures MKI Ltd., Director of LifeBond Ltd., Director of CorAssist Cardiovascular Ltd., Independent Non-Executive Director of Vascular Biogenics Ltd., Director of Nephera Ltd., Director of FertiSeeds Ltd., and Principal of CLAL Israel Ltd.
Dr. Gelvan has an undergraduate and graduate degree from The Hebrew University of Jerusalem and a doctorate from Roskilde University.
Postes actifs de Dan Jacob Gelvan
| Sociétés | Poste | Début |
|---|---|---|
T-Syte Ltd.
 T-Syte Ltd. Miscellaneous Commercial ServicesCommercial Services T-Syte Ltd. operates as an Israeli healthcare venture lab. It focuses on digital health, impact medicine, and medical devices. The company was founded by Yehoshua Etrog and is headquartered in Herzliya, Israel. | Directeur Général | - |
| Agplenus | Directeur Général | 19/02/2024 |
Anciens postes connus de Dan Jacob Gelvan
| Sociétés | Poste | Fin |
|---|---|---|
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Directeur Général | 06/06/2005 |
I2O Pharma Ltd.
 I2O Pharma Ltd. Pharmaceuticals: MajorHealth Technology I2O Pharma Ltd. was specialized in switching injectable drugs to oral formulation. The company was founded in 2011 and was headquartered in Ramat Gan, Israel. | Directeur Général | - |
Beta-O2 Technologies Ltd.
 Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Président | - |
| CLAL Israel Ltd. | Corporate Officer/Principal | - |
Zetiq Technologies Ltd.
 Zetiq Technologies Ltd. Pharmaceuticals: MajorHealth Technology Zetiq Technologies Ltd. provides non-cytotoxic anti-cancer drugs. Its products include CamaRx, CamaDx, and CamaGex. The company distributes its products throughout Israel. Zetiq Technologies was founded in 1997 and is headquartered in Ramat Gan, Israel | Fondateur | - |
Formation de Dan Jacob Gelvan
| The Hebrew University of Jerusalem | Graduate Degree |
| Roskilde University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
IntelliDx, Inc.
 IntelliDx, Inc. Electronic Equipment/InstrumentsElectronic Technology IntelliDx, Inc. develops medical devices. It offers automated ex vivo blood analysis systems that measure the constituents of flowing human blood, and automated blood glucose monitoring systems that measure glucose in hospitalized patients who have abnormally elevated sugar levels. The company was founded in 2000 and is headquartered in Santa Clara, CA. | Electronic Technology |
Zetiq Technologies Ltd.
Zetiq Technologies Ltd. Pharmaceuticals: MajorHealth Technology Zetiq Technologies Ltd. provides non-cytotoxic anti-cancer drugs. Its products include CamaRx, CamaDx, and CamaGex. The company distributes its products throughout Israel. Zetiq Technologies was founded in 1997 and is headquartered in Ramat Gan, Israel | Health Technology |
Aurum Ventures MKI Ltd.
 Aurum Ventures MKI Ltd. Investment ManagersFinance Aurum Ventures MKI Ltd (Aurum Ventures) is a venture capital subsidiary of Morris Kahn founded in 1998 by Morris Kahn. The firm is headquartered in Tel Aviv, Israel. | Finance |
LifeBond Ltd.
 LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Health Technology |
CorAssist Cardiovascular Ltd.
 CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Health Technology |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Beta-O2 Technologies Ltd.
Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Health Technology |
| CLAL Israel Ltd. | Process Industries |
Nephera Ltd.
 Nephera Ltd. Medical SpecialtiesHealth Technology Nephera Ltd. develops products to protect the kidneys via neuro-hormonal modulation. Its technology is based on electrical stimulation of the urinary bladder in order to improve renal function using natural mechanisms. The firm's product RenaSense, which is a medical device that improves and maintains kidney functionality in patients suffering from decompensate heart failure. The company was founded by Gill Bar-Yoseph and Yair Feld in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Vecta Ltd.
 Vecta Ltd. Medical SpecialtiesHealth Technology Vecta Ltd. develops products for the gastrointestinal diseases. Its product VECAM-111 meets a well-known unmet need to address symptoms of gastroesophageal reflux disease (GERD) that are not commonly addressed by existing therapeutic options. The company develops enhanced novel drug formulation for symptomatic GERD. Vecta was founded by Yehuda Chowers and Dan J. Gelvan in 2001 and is headquartered in Ramat Gan, Israel. | Health Technology |
FertiSeeds Ltd.
 FertiSeeds Ltd. Chemicals: AgriculturalProcess Industries FertiSeeds Ltd. develops technology for producing high yield hybrid seeds. It focuses on development of unique, state-of-the-art technologies with wide global applications and on speedy commercialization. The company was founded by Max Herzberg and Shamay Izhar in 2000 and is headquartered in Ness Ziona, Israel. | Process Industries |
I2O Pharma Ltd.
I2O Pharma Ltd. Pharmaceuticals: MajorHealth Technology I2O Pharma Ltd. was specialized in switching injectable drugs to oral formulation. The company was founded in 2011 and was headquartered in Ramat Gan, Israel. | Health Technology |
T-Syte Ltd.
T-Syte Ltd. Miscellaneous Commercial ServicesCommercial Services T-Syte Ltd. operates as an Israeli healthcare venture lab. It focuses on digital health, impact medicine, and medical devices. The company was founded by Yehoshua Etrog and is headquartered in Herzliya, Israel. | Commercial Services |
| Agplenus |
